Company Profile

Terumo Corporation (OTC: TRUMY)
4:51 PM UTC, 07/03/24
Last: $16.63 Change: +0.43 %Change: +2.65% Volume: 56,997
Detailed Quote
Open: $ 15.94   Volume: 56,997
High: $ 16.63   Yield(%) 0.66
Low: $ 15.94   P/E Ratio (ttm): 32.81
Dividend ($): 0.11   Market Cap ($): 24.08B
EPS ($) 0.31   Shares Out: 1.48B
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -4.35
% Price Change (last 13 weeks): -9.51
% Price Change (last 26 weeks): -0.37
% Price Change (last 52 weeks): 2.47
% Price Change (year to date): -1.05
Management Effectiveness
Return on Equity (%): 8.60
Return on Assets (%): 6.09
Return on Invested Capital (%): 7.66
Profitability
Gross Profit Margin (%): 49.27
Net Profit Margin (%): 11.54
Operating Profit Margin (%): 14.56
Price & Volume
50-day Moving Average: $16.86
200-day Moving Average: $16.43
Avg. Daily Vol. (last 50 days): 51,796
Avg. Daily Vol. (last 200 days): 75,129
52-wk high: $20.59
52-wk low: $12.55
Bid: $n/a
Ask: $n/a
Company Information
Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan.
Terumo Corporation
2-44-1 Hatagaya Shibuya-Ku
Tokyo TY 151-0072

Phone: 81.3.3374.8111
Fax: n/a
http://www.terumo.co.jp
Per Share Data
Earnings (1year) ($): 0.31
Annual Dividend ($): n/a
Current P/E Ratio (ttm): 32.81
Book Value ($): 5.91
Cash Flow ($): 0.85
Valuation Ratios
Price/Earnings (x): 32.81
Price/Sales (x): 4.29
Price/Book (x): 3.11
Price/Cash Flow (x): 27.04
Financial Strength
Quick Ratio (x): 1.15
Current Ratio (x): 1.90
LT Debt/Equity (x): 7.86
Total Debt/Equity (x): 20.24



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.